tiprankstipranks
OptimizeRx sees FY24 revenue $88M-$92M , consensus $100.69M
The Fly

OptimizeRx sees FY24 revenue $88M-$92M , consensus $100.69M

For the full year 2024, the Company is updating its 2024 guidance and expects revenue to be between $88 million and $92 million with an Adjusted EBITDA to be between $8 million and $10 million.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App